Global Over-The-Counter Drug Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	173 Pages	TechNavio	April, 2023	INF17955015

Best Price Guarantee
Price	from $2,500
Length	173 Pages
Publisher	TechNavio
Published Date	April, 2023
SKU	INF17955015

Global Over-The-Counter Drug Market 2023-2027

Technavio has been monitoring the over-the-counter drug market and is forecast to grow by USD 58.54 bn during 2022-2027, accelerating at a CAGR of 6.53% during the forecast period. Our report on the over-the-counter drug market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by new product launches in the global over-the-counter drug market, the rising prevalence of diseases and otc drug use, and favorable regulatory framework for OTC drugs.

Technavio's over-the-counter drug market is segmented as below:

By Route Of Administration

Oral
Topical
Parenteral
Others

By Distribution Channel

Offline
Online

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing geriatric population as one of the prime reasons driving the over-the-counter drug market growth during the next few years. Also, increasing healthcare expenditure and growing adoption of e-commerce platforms for otc drugs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the over-the-counter drug market covers the following areas:

Over-the-counter drug market sizing
Over-the-counter drug market forecast
Over-the-counter drug market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over-the-counter drug market vendors that include Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca Plc, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Ltd., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group Plc, Sanofi SA, and Zydus Lifesciences Ltd.. Also, the over-the-counter drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market by Geography; Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global over-the-counter drug market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion); 4.2 Route of Administration Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion); 4.3 Distribution Channel Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Route of Administration: 6.1 Market segments; Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%); Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%); 6.2 Comparison by Route of Administration; Exhibit 32: Chart on Comparison by Route of Administration; Exhibit 33: Data Table on Comparison by Route of Administration; 6.3 Oral - Market size and forecast 2022-2027; Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ billion); Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion); Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%); 6.4 Topical - Market size and forecast 2022-2027; Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ billion); Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion); Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%); 6.5 Parenteral - Market size and forecast 2022-2027; Exhibit 42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion); Exhibit 43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion); Exhibit 44: Chart on Parenteral - Year-over-year growth 2022-2027 (%); Exhibit 45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%); 6.6 Others - Market size and forecast 2022-2027; Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.7 Market opportunity by Route of Administration; Exhibit 50: Market opportunity by Route of Administration ($ billion); Exhibit 51: Data Table on Market opportunity by Route of Administration ($ billion)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%); Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%); 7.2 Comparison by Distribution Channel; Exhibit 54: Chart on Comparison by Distribution Channel; Exhibit 55: Data Table on Comparison by Distribution Channel; 7.3 Offline - Market size and forecast 2022-2027; Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ billion); Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion); Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%); Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%); 7.4 Online - Market size and forecast 2022-2027; Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ billion); Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ billion); Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%); Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%); 7.5 Market opportunity by Distribution Channel; Exhibit 64: Market opportunity by Distribution Channel ($ billion); Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 67: Chart on Market share by geography 2022-2027 (%); Exhibit 68: Data Table on Market share by geography 2022-2027 (%); 9.2 Geographic comparison; Exhibit 69: Chart on Geographic comparison; Exhibit 70: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion); Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion); Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion); Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion); Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 Asia - Market size and forecast 2022-2027; Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion); Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion); Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%); 9.6 Rest of World (ROW) - Market size and forecast 2022-2027; Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion); Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion); Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); 9.7 US - Market size and forecast 2022-2027; Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion); Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion); Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%); 9.8 Germany - Market size and forecast 2022-2027; Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ billion); Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion); Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%); 9.9 Japan - Market size and forecast 2022-2027; Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion); Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion); Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%); 9.10 UK - Market size and forecast 2022-2027; Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion); Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion); Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.11 China - Market size and forecast 2022-2027; Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion); Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion); Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%); 9.12 Market opportunity by geography; Exhibit 107: Market opportunity by geography ($ billion); Exhibit 108: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 115: Abbott Laboratories - Overview; Exhibit 116: Abbott Laboratories - Business segments; Exhibit 117: Abbott Laboratories - Key news; Exhibit 118: Abbott Laboratories - Key offerings; Exhibit 119: Abbott Laboratories - Segment focus; 12.4 Achelios Therapeutics Inc.; Exhibit 120: Achelios Therapeutics Inc. - Overview; Exhibit 121: Achelios Therapeutics Inc. - Product / Service; Exhibit 122: Achelios Therapeutics Inc. - Key offerings; 12.5 AstraZeneca Plc; Exhibit 123: AstraZeneca Plc - Overview; Exhibit 124: AstraZeneca Plc - Product / Service; Exhibit 125: AstraZeneca Plc - Key news; Exhibit 126: AstraZeneca Plc - Key offerings; 12.6 Bayer AG; Exhibit 127: Bayer AG - Overview; Exhibit 128: Bayer AG - Business segments; Exhibit 129: Bayer AG - Key news; Exhibit 130: Bayer AG - Key offerings; Exhibit 131: Bayer AG - Segment focus; 12.7 BioGaia AB; Exhibit 132: BioGaia AB - Overview; Exhibit 133: BioGaia AB - Business segments; Exhibit 134: BioGaia AB - Key news; Exhibit 135: BioGaia AB - Key offerings; Exhibit 136: BioGaia AB - Segment focus; 12.8 Boehringer Ingelheim International GmbH; Exhibit 137: Boehringer Ingelheim International GmbH - Overview; Exhibit 138: Boehringer Ingelheim International GmbH - Business segments; Exhibit 139: Boehringer Ingelheim International GmbH - Key news; Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings; Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus; 12.9 Bukwang Pharmaceutical Co. Ltd.; Exhibit 142: Bukwang Pharmaceutical Co. Ltd. - Overview; Exhibit 143: Bukwang Pharmaceutical Co. Ltd. - Product / Service; Exhibit 144: Bukwang Pharmaceutical Co. Ltd. - Key offerings; 12.10 Chr Hansen Holding AS; Exhibit 145: Chr Hansen Holding AS - Overview; Exhibit 146: Chr Hansen Holding AS - Business segments; Exhibit 147: Chr Hansen Holding AS - Key news; Exhibit 148: Chr Hansen Holding AS - Key offerings; Exhibit 149: Chr Hansen Holding AS - Segment focus; 12.11 CVS Health Corp.; Exhibit 150: CVS Health Corp. - Overview; Exhibit 151: CVS Health Corp. - Business segments; Exhibit 152: CVS Health Corp. - Key news; Exhibit 153: CVS Health Corp. - Key offerings; Exhibit 154: CVS Health Corp. - Segment focus; 12.12 GlaxoSmithKline Plc; Exhibit 155: GlaxoSmithKline Plc - Overview; Exhibit 156: GlaxoSmithKline Plc - Business segments; Exhibit 157: GlaxoSmithKline Plc - Key news; Exhibit 158: GlaxoSmithKline Plc - Key offerings; Exhibit 159: GlaxoSmithKline Plc - Segment focus; 12.13 Johnson and Johnson Services Inc.; Exhibit 160: Johnson and Johnson Services Inc. - Overview; Exhibit 161: Johnson and Johnson Services Inc. - Business segments; Exhibit 162: Johnson and Johnson Services Inc. - Key news; Exhibit 163: Johnson and Johnson Services Inc. - Key offerings; Exhibit 164: Johnson and Johnson Services Inc. - Segment focus; 12.14 Novartis AG; Exhibit 165: Novartis AG - Overview; Exhibit 166: Novartis AG - Business segments; Exhibit 167: Novartis AG - Key offerings; Exhibit 168: Novartis AG - Segment focus; 12.15 Pfizer Inc.; Exhibit 169: Pfizer Inc. - Overview; Exhibit 170: Pfizer Inc. - Product / Service; Exhibit 171: Pfizer Inc. - Key news; Exhibit 172: Pfizer Inc. - Key offerings; 12.16 Reckitt Benckiser Group Plc; Exhibit 173: Reckitt Benckiser Group Plc - Overview; Exhibit 174: Reckitt Benckiser Group Plc - Business segments; Exhibit 175: Reckitt Benckiser Group Plc - Key offerings; Exhibit 176: Reckitt Benckiser Group Plc - Segment focus; 12.17 Sanofi SA; Exhibit 177: Sanofi SA - Overview; Exhibit 178: Sanofi SA - Business segments; Exhibit 179: Sanofi SA - Key news; Exhibit 180: Sanofi SA - Key offerings; Exhibit 181: Sanofi SA - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 182: Inclusions checklist; Exhibit 183: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 184: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 185: Research methodology; Exhibit 186: Validation techniques employed for market sizing; Exhibit 187: Information sources; 13.5 List of abbreviations; Exhibit 188: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion); Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion); Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%); Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by Route of Administration; Exhibits33: Data Table on Comparison by Route of Administration; Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ billion); Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion); Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Topical - Market size and forecast 2022-2027 ($ billion); Exhibits39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion); Exhibits40: Chart on Topical - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Topical - Year-over-year growth 2022-2027 (%); Exhibits42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion); Exhibits43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion); Exhibits44: Chart on Parenteral - Year-over-year growth 2022-2027 (%); Exhibits45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%); Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits50: Market opportunity by Route of Administration ($ billion); Exhibits51: Data Table on Market opportunity by Route of Administration ($ billion); Exhibits52: Chart on Distribution Channel - Market share 2022-2027 (%); Exhibits53: Data Table on Distribution Channel - Market share 2022-2027 (%); Exhibits54: Chart on Comparison by Distribution Channel; Exhibits55: Data Table on Comparison by Distribution Channel; Exhibits56: Chart on Offline - Market size and forecast 2022-2027 ($ billion); Exhibits57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion); Exhibits58: Chart on Offline - Year-over-year growth 2022-2027 (%); Exhibits59: Data Table on Offline - Year-over-year growth 2022-2027 (%); Exhibits60: Chart on Online - Market size and forecast 2022-2027 ($ billion); Exhibits61: Data Table on Online - Market size and forecast 2022-2027 ($ billion); Exhibits62: Chart on Online - Year-over-year growth 2022-2027 (%); Exhibits63: Data Table on Online - Year-over-year growth 2022-2027 (%); Exhibits64: Market opportunity by Distribution Channel ($ billion); Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits67: Chart on Market share by geography 2022-2027 (%); Exhibits68: Data Table on Market share by geography 2022-2027 (%); Exhibits69: Chart on Geographic comparison; Exhibits70: Data Table on Geographic comparison; Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ billion); Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ billion); Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ billion); Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion); Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ billion); Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion); Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion); Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion); Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion); Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion); Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ billion); Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion); Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ billion); Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion); Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion); Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion); Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion); Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion); Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits107: Market opportunity by geography ($ billion); Exhibits108: Data Tables on Market opportunity by geography ($ billion); Exhibits109: Impact of drivers and challenges in 2022 and 2027; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: Abbott Laboratories - Overview; Exhibits116: Abbott Laboratories - Business segments; Exhibits117: Abbott Laboratories - Key news; Exhibits118: Abbott Laboratories - Key offerings; Exhibits119: Abbott Laboratories - Segment focus; Exhibits120: Achelios Therapeutics Inc. - Overview; Exhibits121: Achelios Therapeutics Inc. - Product / Service; Exhibits122: Achelios Therapeutics Inc. - Key offerings; Exhibits123: AstraZeneca Plc - Overview; Exhibits124: AstraZeneca Plc - Product / Service; Exhibits125: AstraZeneca Plc - Key news; Exhibits126: AstraZeneca Plc - Key offerings; Exhibits127: Bayer AG - Overview; Exhibits128: Bayer AG - Business segments; Exhibits129: Bayer AG - Key news; Exhibits130: Bayer AG - Key offerings; Exhibits131: Bayer AG - Segment focus; Exhibits132: BioGaia AB - Overview; Exhibits133: BioGaia AB - Business segments; Exhibits134: BioGaia AB - Key news; Exhibits135: BioGaia AB - Key offerings; Exhibits136: BioGaia AB - Segment focus; Exhibits137: Boehringer Ingelheim International GmbH - Overview; Exhibits138: Boehringer Ingelheim International GmbH - Business segments; Exhibits139: Boehringer Ingelheim International GmbH - Key news; Exhibits140: Boehringer Ingelheim International GmbH - Key offerings; Exhibits141: Boehringer Ingelheim International GmbH - Segment focus; Exhibits142: Bukwang Pharmaceutical Co. Ltd. - Overview; Exhibits143: Bukwang Pharmaceutical Co. Ltd. - Product / Service; Exhibits144: Bukwang Pharmaceutical Co. Ltd. - Key offerings; Exhibits145: Chr Hansen Holding AS - Overview; Exhibits146: Chr Hansen Holding AS - Business segments; Exhibits147: Chr Hansen Holding AS - Key news; Exhibits148: Chr Hansen Holding AS - Key offerings; Exhibits149: Chr Hansen Holding AS - Segment focus; Exhibits150: CVS Health Corp. - Overview; Exhibits151: CVS Health Corp. - Business segments; Exhibits152: CVS Health Corp. - Key news; Exhibits153: CVS Health Corp. - Key offerings; Exhibits154: CVS Health Corp. - Segment focus; Exhibits155: GlaxoSmithKline Plc - Overview; Exhibits156: GlaxoSmithKline Plc - Business segments; Exhibits157: GlaxoSmithKline Plc - Key news; Exhibits158: GlaxoSmithKline Plc - Key offerings; Exhibits159: GlaxoSmithKline Plc - Segment focus; Exhibits160: Johnson and Johnson Services Inc. - Overview; Exhibits161: Johnson and Johnson Services Inc. - Business segments; Exhibits162: Johnson and Johnson Services Inc. - Key news; Exhibits163: Johnson and Johnson Services Inc. - Key offerings; Exhibits164: Johnson and Johnson Services Inc. - Segment focus; Exhibits165: Novartis AG - Overview; Exhibits166: Novartis AG - Business segments; Exhibits167: Novartis AG - Key offerings; Exhibits168: Novartis AG - Segment focus; Exhibits169: Pfizer Inc. - Overview; Exhibits170: Pfizer Inc. - Product / Service; Exhibits171: Pfizer Inc. - Key news; Exhibits172: Pfizer Inc. - Key offerings; Exhibits173: Reckitt Benckiser Group Plc - Overview; Exhibits174: Reckitt Benckiser Group Plc - Business segments; Exhibits175: Reckitt Benckiser Group Plc - Key offerings; Exhibits176: Reckitt Benckiser Group Plc - Segment focus; Exhibits177: Sanofi SA - Overview; Exhibits178: Sanofi SA - Business segments; Exhibits179: Sanofi SA - Key news; Exhibits180: Sanofi SA - Key offerings; Exhibits181: Sanofi SA - Segment focus; Exhibits182: Inclusions checklist; Exhibits183: Exclusions checklist; Exhibits184: Currency conversion rates for US$; Exhibits185: Research methodology; Exhibits186: Validation techniques employed for market sizing; Exhibits187: Information sources; Exhibits188: List of abbreviations